- Home
- Shop
- Research Peptides
- Semax 5 mg
Semax 5 mg
Semax is a heptapeptide nootropic studied for cognitive enhancement, neuroprotection, and BDNF modulation in neural research models.
$285.00 – $350.00Price range: $285.00 through $350.00
Availability:
30 in stock (can be backordered)
Ships today. Additional quantities may be backordered. Backordered items ship in 7-10 business days.
Semax is a heptapeptide nootropic studied for cognitive enhancement, neuroprotection, and BDNF modulation in neural research models.
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
CAS Number
1380139-42-2
Purity
99.9%
Format
Lyophilized powder
Lot Number
AET-5-AMINO-50MG-09472
Purity (HPLC)
99.9%
Molecular Mass
4732.2 Da
Test Method
HPLC + Mass Spectrometry
Verified
Independent laboratory
Store lyophilized peptides at -20°C upon receipt. Reconstitute with bacteriostatic water and aliquot to avoid repeated freeze-thaw cycles. Reconstituted solutions should be stored at 2–8°C for short-term use or -20°C for long-term storage. Protect from light.
You May Also Like
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, engineered for advanced metabolic research applications.
Research Peptides
5-Amino-1MQ is a small-molecule inhibitor studied for adipose tissue metabolism and NNMT pathway modulation in metabolic research.



